DUX4 and sarcoma: In addition, considering the dependence of CIC-DUX4 sarcoma on the CCNE-CDK2 cell cycle complex [31], the effects of pharmacological inhibition of CDK2, a CCNE1 binding partner, were investigated in CIC-DUX4 cells.